AI CAN CERV: LAUNCH OF AI-ASSISTED CERVICAL SCREENING TECHNOLOGY IN THE PHILIPPINES
Our month-long celebration of 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐞𝐫𝐯𝐢𝐜𝐚𝐥 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡 has culminated in this momentous event.
This May 31st, CerviQ is launching 𝐀𝐈 𝐂𝐀𝐍 𝐂𝐄𝐑𝐕, which signifies our commitment to helping save women’s lives in our country. Together with the rest of the world, we pledge our participation in WHO’s Global Initiative to eradicate cervical cancer. The event’s highlight is the signing of the 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 𝐂𝐞𝐫𝐯𝐢𝐐 𝐚𝐧𝐝 𝐀𝐈𝐃𝐎𝐓 𝐨𝐟 𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚.
𝐀𝐈𝐃𝐎𝐓 is one of the leading medical software developers in South Korea, pioneering in Artificial Intelligence (AI). Their flagship product 𝐂𝐄𝐑𝐕𝐈𝐑𝐀𝐘 𝐀𝐈 is a cutting-edge digital cervicography diagnostic solution device that combines traditional cervical enlargement photography and artificial intelligence.
𝐂𝐞𝐫𝐯𝐢𝐐, a social enterprise in the Philippines, advocates eradicating cervical cancer through prevention, screening, and treatment guided by the World Health Organization (WH0) 90-70-90 Roadmap to 2030.
CerviQ, with the use of CERVIRAY AI, will spearhead AI-Assisted Cervical Screening technology in the Philippines to make cervical cancer screening:
- faster (results are available within 5 minutes)
- easy to use (portable handheld device)
- accessible (transportable, no infrastructure needed)
- and more accurate (93% sensitivity, 89% specificity)
Join us this 𝐌𝐨𝐧𝐝𝐚𝐲 𝐚𝐭 𝟗 𝐀𝐌 𝐨𝐧 𝐂𝐞𝐫𝐯𝐢𝐐 𝐚𝐧𝐝 𝐂𝐞𝐫𝐯𝐢𝐐 𝐓𝐕 𝐏𝐥𝐮𝐬 and celebrate this milestone in cervical screening technology.